Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fexuprazan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech
    Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech

    09 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-unveils-innovative-drug-delivery-technologies-in-milanfrom-worlds-first-microneedle-therapy-to-once-a-month-obesity-treatment-302272175.html

    PR NEWSWIRE
    09 Oct 2024
    Share Share
    Daewoong Regaining Rights to Fexuprazan in the USA and Canada
    Daewoong Regaining Rights to Fexuprazan in the USA and Canada

    05 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-regaining-rights-to-fexuprazan-in-the-united-states-and-canada-upon-termination-of-license-agreement-with-neurogastrx-301841938.html

    PR NEWSWIRE
    05 Jun 2023
    Share Share
    Daewoong applies for approving its GE reflux drug in 4 Latin American countries
    Daewoong applies for approving its GE reflux drug in 4 Latin American countries

    23 May 2022

    // Lee Han-soo KOREABIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=13739

    Lee Han-soo KOREABIOMED
    23 May 2022
    Share Share
    Neurogastrx Agreement with Daewoong Pharmaceutical to Develop Fexuprazan
    Neurogastrx Agreement with Daewoong Pharmaceutical to Develop Fexuprazan

    08 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/neurogastrx-announces-agreement-with-daewoong-pharmaceutical-to-develop-fexuprazan-for-treatment-of-acid-related-gi-disorders-in-the-us-301308153.html

    PRNEWSWIRE
    08 Jun 2021
    Share Share